OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GLSI

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Greenwich LifeSciences (GLSI) Earnings Date & Reports

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GLSI is expected to report earnings to fall 23.33% to -23 cents per share on November 10

Greenwich LifeSciences GLSI Stock Earnings Reports

Q3'25

Est.

$-0.23

Q2'25

Missed

by $0.06

Q1'25

Missed

by $0.03

Q4'24

Missed

by $0.40

Q2'24

Est.

$-0.20

The last earnings report on August 26 showed earnings per share of -30 cents, missing the estimate of -23 cents. With 6.20K shares outstanding, the current market capitalization sits at 162.61M.

View a ticker or compare two or three

Compare

GLSI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GLSI
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GLSI showed earnings on August 26, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3992 Bluebonnet Drive

Phone

+1 832 819-3232

Employees

Web

https://www.greenwichlifesciences.com